Hello, my name is Janet Pope and I am a rheumatologist in Canada with a specific interest in scleroderma, especially clinical trials and clinical research studies. I am an Associate Professor of the Department of Medicine, Division of Rheumatology and Epidemiology and Biostatistics at the University of Western Ontario, London, Ontario, Canada.
I obtained my MD and Fellowship in Internal Medicine at the University of Western Ontario. I acquired a Fellowship in Rheumatology and Masters of Public Health at Boston University. I completed a Canadian Arthritis Society Research Fellowship In London, Ontario in scleroderma, and then became a member of the Division of Rheumatology. I am currently Program Director in Rheumatology, sit on five Advisory Boards, and am member of the Scleroderma Clinical Trials Consortium.
I have published over fifty research articles pertaining to rheumatic diseases. I look forward to sharing my expertise in this field. My email address is [email protected].
Treatment of Systemic Sclerosis Complications. What to use when first-line treatment fails; a consensus of systemic sclerosis experts. Symptoms treatment recommendations by over 100 scleroderma experts, for scleroderma renal crisis (SRC), digital ulcers (DU), pulmonary hypertension (PAH/PH), reflux, skin involvement, and arthritis. Seminars in Arthritis and Rheumatism Volume 42, Issue 1 , Pages 42-55, August 2012. (Also see Scleroderma Renal Crisis, Digital Ulcers, Pulmonary Hypertension, Reflux, Skin Involvement, Skeletal Involvement, and Scleroderma Treatments)
ISN Liaison to Medical Advisory Board
Medical Advisory Board Members
|Foster, C. Stephen||U.S.|
|Van den Hoogen, Frank*||Netherlands|
|* = Need ISN Profile Submitted|
Prevalence of Elevated Pulmonary Arterial Pressures Measured by Echocardiography in a Multicenter Study of Patients with Systemic Sclerosis. Elevated pulmonary arterial pressures (PAP) are common in both limited and diffuse SSc disease, occurring in 21% of limited and 26% of diffuse SSc patients. A high index of suspicion is important and routine echocardiography in symptomatic patients may allow earlier diagnosis of PAH and intervention. J Rheumatol. 2005 July;32:1273-8. (Also see Pulmonary Hypertension, Limited Scleroderma, and Diffuse Scleroderma)
Kym: Diffuse, CREST Scleroderma, Lupus and Fibromyalgia It all started with Raynaud's in my fingers and toes when I was about nineteen years old, in 1979…
United Way of Central New Mexico
United Way of Snohomish County
See ISN News for recent donors, including Pam Hop, Margaret Roof, Winifred Schillberg, Arnold Slotkin, and Juliet Youkhana. Plus donations in honor of Kim Thwaits, and in loving memory of Marta Marx, Jim Miller, and Arlene Marie Petulla.
Click Here to Donate or Shop
or click on the floating green DONATE sclero.org button.
SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to: